Facebook Instagram X-twitter Linkedin

MOTS-C (40mg)

Table of Contents

  • Quickstart Highlights

MOTS-C (40mg) protocols focus on this mitochondria-derived peptide studied for its potential role in regulating metabolic homeostasis, improving insulin sensitivity, and enhancing cellular energy efficiency. It is believed to act through AMPK-related pathways, supporting fat metabolism and exercise endurance. This guide outlines a subcutaneous administration approach optimized for the 40 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 20 mg/mL concentration
  • Typical daily range: 5–20 mg (depending on protocol and cycling approach)
  • Easy measuring: At 20 mg/mL, 1 unit = 0.01 mL = 200 mcg (0.2 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support metabolic flexibility, insulin sensitivity, and energy regulation
  • Schedule: Daily or cycling-based subcutaneous use depending on protocol
  • Dose Range: 5–20 mg per day or per cycle, depending on application
  • Dosing Protocol

Suggested approach for the 40 mg vial format.

  • Start: 5 mg per dose to assess tolerance
  • Target: 10–20 mg per day in divided doses
  • Frequency: Once or twice daily (subcutaneous) or cycle-based protocols
  • Vial Duration: One 40 mg vial typically lasts 2–8 days, depending on dosing
  • Timing: Often used in the morning or pre-activity for metabolic support
  • Mechanism of Action

MOTS-C is a mitochondria-encoded peptide involved in cellular energy regulation. It is believed to influence metabolic homeostasis by activating AMPK (adenosine monophosphate-activated protein kinase), a key energy sensor in cells.

Through AMPK activation, MOTS-C may enhance glucose uptake, improve insulin sensitivity, and promote fatty acid oxidation. It is also studied for its role in improving exercise capacity and metabolic adaptation under stress conditions. Unlike many peptides that act via hormonal pathways, MOTS-C works primarily at the mitochondrial and cellular energy signaling level.

  • Potential Benefits & Side Effects

Observations based on preclinical and early research.

Potential Benefits:

  • May improve insulin sensitivity and glucose metabolism
  • May enhance fat oxidation and metabolic efficiency
  • May support exercise endurance and performance adaptation
  • May assist in cellular energy balance and mitochondrial health

Possible Side Effects:

  • Mild fatigue or energy fluctuations during adaptation
  • Temporary headache or dizziness in some cases
  • Injection-site irritation
  • Long-term human data is still limited; it remains investigational